TerminatedPHASE1, PHASE2NCT02189889

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Philip E. Greilich, MD
University of Texas Southwestern Medical Center
Intervention
EPO(drug)
Enrollment
5 enrolled
Eligibility
18-80 years · All sexes
Timeline
20132019

Study locations (1)

Collaborators

AMAG Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02189889 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials